Non-Vegetarian Ingredient In Herbal Tooth Powder, Delhi HC Issues Notice To Patanjali Ayurveda And Baba Ramdev

New Delhi: Patanjali Ayurved Limited, led by yoga guru Ramdev, is once again under legal scrutiny as the Delhi high court has demanded responses from the Centre, the Food Safety and Standards Authority of India (FSSAI), and the company over a petition alleging misbranding of its “Divya Dant Manjan” dental care product.

The petition, filed by lawyer Yatin Sharma, claims that despite “Divya Dant Manjan” being marketed with a green dot — an indicator of vegetarian status — it actually contains “samudraphen,” a fish-derived compound.

This, according to Sharma, constitutes “misbranding” under the Drugs and Cosmetics Act. Although the law does not mandate specific labelling for drugs as vegetarian or non-vegetarian, the use of the green dot qualifies as “misbranding” under the Drugs and Cosmetics Act, the petitioner’s counsel argued.

Justice Sanjeev Narula issued notice to the Centre, the FSSAI as well as Patanjali, Divya Pharmacy, Yoga guru Ramdev and other related parties on Sharma’s petition.

The petitioner, represented by advocates Swapnil Chaudhary and Prashant Gupta, said the discovery was “distressing” for him and his family, particularly because they adhere to a strict vegetarian diet due to religious beliefs.

“Respondent No. 3 (Patanjali Ayurveda) is selling the same product with a green dot on their official website, indicating that the product is vegetarian in nature, which is contradictory.

“The Petitioner seeks redressal for the profound distress caused by the inadvertent consumption of a non-vegetarian product, emphasizing the importance of upholding religious beliefs and ensuring transparency in product representation,” the petition, filed through lawyers Mohit Solanki and Pulkit Chaudhary, stated.

The matter would be heard next in November.

Related Posts

  • Pharma
  • September 16, 2024
  • 43 views
All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

New Delhi: The National Medical Commission (NMC) has initiated the process of registration of all MBBS doctors eligible to practice in India on a recently launched portal, as a part of…

  • Pharma
  • September 16, 2024
  • 53 views
ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

New Delhi: In a significant stride towards strengthening India’s clinical research ecosystem, the Indian Council of Medical Research (ICMR) has formalized Memorandum of Agreements (MoAs) with multiple sponsors under its Network…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

All Doctors To Have Unique IDs; NMC Starts Registration On Its New Portal

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

ICMR Signs MoAs To Advance First-In-Human Clinical Trials For Four Promising Molecules

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

Balaji Action Hsopital now equipped with Robotic System to Revolutionize Surgery

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

1680 Onerex Cough Syrup Bottles Loaded In A Luxury Car Seized, One Arrested

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DCC Once Again Sensitises State Regulators To Submit NSQ Data On Time

DRI seizes alprazolam tablets worth Rs 30 lakh

DRI seizes alprazolam tablets worth Rs 30 lakh